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ABSTRACT 
 
Cancer, a disease of an uncontrolled cell division, growth and metastasis as a result 
of genetic mutations, environmental factors and host response, is affecting populations 
worldwide. Etiology, pathogenicity, and genetics related to cancer are not well understood, 
and treatment has not been as effective as scientists have expected. Continual research is 
being done to improve current understanding and treatments.  
 
Oral squamous cell carcinoma (OSCC) is one of the most common head and neck 
cancers (representing >90 % of all head and neck cancers) involving neoplasms of the oral 
cavity and oropharynx. OSCC is a very pernicious malignancy developed from epithelial 
cells. There is evidence that a key N-glycosylation gene, DPAGT1, is associated with 
cancer. Although N-glycosylation of proteins is involved in organ development and 
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homeostasis of tissue, overexpression of DPAGT1 has been implicated in oral cancer 
initiation and metastasis. Defects in N-glycosylation underlie congenital disorders, while 
hyper-N-glycosylation has been shown to be a feature of many cancers.  
 
The N-glycosylation pathway directs cell adhesion and cytoskeletal dynamics by 
impacting the function of E-cadherin, a major epithelial cell-cell adhesion receptor. E-
cadherin is a tumor suppressor responsible for the organization of multiprotein complexes 
named adherens junctions (AJs). In epithelial cells, stable AJs are essential for several 
cellular processes, including inhibition of cell proliferation, reorganization of the actin 
cytoskeleton, and maintenance of an epithelial phenotype.  Indeed, restoration of AJs has 
been shown to revert cancer cells from a mesenchymal to an epithelial phenotype and to 
reduce invasiveness. Previous work has shown that upregulation of DPAGT1 plays a 
pivotal role in driving canonical WNT/β-catenin signaling (also known as canonical Wnt 
signaling) that represses E-cadherin adhesions and drives tumorigenic phenotypes in oral 
cancer. This suggests a role in coordinating balance between proliferation and adhesion by 
DPAGT1.   
 
To date, little is known about the molecular and cellular details underlying 
differences among OSCC cell lines. CAL 27 and HSC-3 are human cancer cell lines 
commonly used to in laboratory OSCC research. The main differences between these cell 
lines include capsular tumors formed by CAL27 cells in nude mouse models in contrast to 
non-capsular and invasive tumors formed by HSC-3 cells. The goal of this study was to 
characterize biochemical differences between these two cell lines for further research. 
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INTRODUCTION  
 
 Oral squamous cell carcinoma (OSCC) cell lines serve as important tools in 
decoding the underlying mechanisms of OSCC pathogenesis and identifying potential new 
therapies.  Currently, a considerable number of OSCC cell lines derived from patients is 
available. However, since the growth patterns, differentiation and metastatic abilities vary 
among these cells lines, it is more difficult to build models for in vivo and in vitro studies 
when attempting to study stage-specific pathobiology of OSCC.  
 
Biochemical and molecular characterization of these cell lines and alignment with 
histopathological features are imperative for the design of improved models to study OSCC. 
In 1982, Gioanni and colleagues established the CAL27 OSCC cell line from a tumor tissue 
of a 56-year-old Caucasian male with poorly differentiated squamous cell carcinoma of the 
middle of the tongue (Gioanni et al., 1988). The tumorigenicity of CAL27 cells was 
confirmed in athymic nude mice. Histological examination of CAL27 xenografts exhibited 
well-differentiated squamous cell carcinomas at varying degrees of maturity. Since then, 
the CAL27 cell line has been widely used to build OSCC models for in-vivo and in-vitro 
studies, and it is regarded as a representative cell line of OSCC (Herak Bosnar et al., 2008).  
 
The HSC-3 cells represent another cell line used to model OSCC. This cell line was 
first established in Japan from cells derived from a 64-year-old male patient with a primary 
moderately differentiated tumor located in the tongue with lymph nodes metastasis (Erdem 
et al, 2007). 
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Protein N-glycosylation is an essential post-translational modification of proteins 
with critical roles in cellular functions that are vital for organ development, homeostasis 
and cancer (Stanley, 2009).  In humans, mutations in DPAGT1 lead to alterations in the 
activity of its protein product, the enzyme dolichol-phosphate-dependent N-
acetylglucosamine-1-phospho transferase, GPT, giving rise to congenital disorders of 
glycosylation and early mortality (Wu, et al. 2003). N-glycans control the activity of a 
wide-range of proteins, including the presentation of different cell surface receptors, such 
as markers of stem cell state (CD44, CD29) and receptor tyrosine kinases, such as EGFR 
and FGFR, with roles in OSCC pathogenesis.  
 
Dysregulation of N-glycosylation and hyper-N-glycosylation of proteins, in 
particular, is a feature of many cancers, including OSCC. Despite the importance of N-
glycosylation in cellular processes, the molecular mechanisms by which N-glycosylation 
directs cancer signaling pathways are not well understood. Due to environmental, genetic, 
epigenetic, viral and host response factors, the etiology OSCC has not yet been determined. 
However, OSCC is known to develop through a multistep process by mechanisms that 
promote tumor initiation (neoplasm), progression and metastasis accompanied by complex 
pathologic characteristics (Hanahan et al., 2011).   
 
Recent studies have further implicated N-glycosylation as a major player regulating 
various aspects of tumorigenesis (Guo et al. 2010). Specifically, carcinomas or cancers of 
epithelial origin are associated with dramatic inhibition of cell-cell junctions, aberrant 
organization of cell polarity and cytoskeletal architecture (Wodarz, 2007) as a result of 
dysregulated signaling pathways giving cells the ability to resist apoptosis, increasing 
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proliferation rates and, in extreme cases, to metastasize to distant tissues (Dhillon et al, 
2007). Increasingly, N-glycans have emerged as key players in regulating cellular signaling 
pathways, including the activities of receptor tyrosine kinases, such as EGFR and FGFR, 
known to drive OSCC progression. Further, to date, EGFR is the only FDA-approved target 
for OSCC therapy that disappointingly has had only limited success.   
 
The N-glycosylation pathway is initiated in the endoplasmic reticulum (ER) with 
the synthesis of the lipid-linked oligosaccharide (LLO) precursor, which is then transferred 
co-translationally to newly synthesized polypeptides (Stanley, 2009). As glycoproteins 
transit from the ER to Golgi, N-glycans are modified so that mature N-glycoproteins are 
decorated with structures ranging from high mannose/hybrid to complex oligosaccharides.  
 
The N-glycosylation gene, DPAGT1, encodes the GPT enzyme that functions at the 
first committed step in in LLO synthesis that involves the transfer of GlcNAc-P from UDP-
GlcNAc to dolichol-phosphate to produce dolichol-PP-GlcNAc (Kukuruzinska et al., 1994) 
(Figure 1). Since the hexosamine pathway utilizes fructose-6-phosphate from glycolysis to 
synthesize UDP-GlcNAc, DPAGT1 integrates glucose metabolism with protein N-
glycosylation, a property relevant to hyper-metabolic features of tumors (Dennis et al., 
2009). 
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Figure 1. Schematic of the N-glycosylation pathway. Showing DPAGT1 at the first and 
rate-limiting step in the endoplasmic reticulum (ER), which initiates the synthesis of lipid-
linked oligosaccharide (LLO) precursor. LLO is transferred co-translationally to newly 
synthesized polypeptides. After initial processing steps in the ER, glycoproteins transits to 
the Golgi, where N-glycans are further modified to produce oligosaccharides ranging from 
high mannose/hybrid (ConA-binding) to complex (PHA-binding). 
 
Intercellular adhesion is a key feature of multicellular organisms and is necessary 
for the establishment of cell polarity (Green et al, 2010). In epithelial tissues, establishment 
of a mature polarized architecture, organization and function is achieved by intercellular 
junctions (Hirano et al., 1987) that include adherens junctions (AJs) and tight junctions 
(TJs), where the latter are responsible for the barrier function of the epithelia (Niessen et al, 
2007).   
 
A principle mediator in forming AJs in epithelial cells is a transmembrane 
glycoprotein, E-cadherin, encoded by the CDH1 gene. E-cadherin is associated with 
cytoplasmic proteins from the armadillo family and has intra-cellular and extracellular 
domains. The extracellular domain contains five repeat sequences that bind cadherins on 
adjacent cells (Figure 2). The cytosolic tail interacts with the catenin protein family which 
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in turn mediates interactions with the actin cytoskeleton, together establishing mature AJs 
(Cavey et al, 2009).  
 
	  
Figure 2. Schematic of E-cadherin mediated cell-cell adhesion. The extracellular domain 
of E-cadherin contains five repeated sequences that mediate hemophilic binding. The 
cytosolic domain contains the binding site for catenins which mediate attachment to the 
actin cytoskeleton. (Figure taken from Parades et al., 2012) 
 
Establishment of AJs is important for epithelial tissue homeostasis (cell-cell 
adhesion). Dysfunction of AJs results in a series of events that lead to human cancer 
initiation, development and eventually metastasis in different epithelial organs including 
OSCC (Jamal et al, 2012).  Previous studies have shown that hyper-glycosylation of E-
cadherin driven by inappropriately high DPGT1 expression in OSCC is associated with loss 
of stable AJs and cellular discohesion (Nita-Lazar et al, 2009).   
 
The oligosaccharides that comprise N-glycans have varying structures determined 
by variable expression of multiple glycosyltransferases (Pinho et al., 2010). The structures 
that are defined by activities of various glycosyltransferases are grouped into three different 
classes. First, the high mannose class is characterized by the core glycan being bound only 
by mannose monosaccharides. Second, the complex class of N-glycans includes glycans 
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that exhibit antennae attached to the core glycan. The third class includes hybrid glycans 
characterized by mannose monosaccharides attached to the Manα1-6 arm of the core and by 
one or two antennae attached to the Manα1-3 arm (Pinho et al., 2010).  
 
Evidence has shown that N-glycosylation is a key factor in cell-cell adhesion. The 
structure of N-glycans can impact cell-cell and cell-extracellular matrix interfaces that 
affect adhesion, proliferation, migration and invasion (Asada et al., 1997). For example, E-
cadherin that bears complex N-glycan modifications is associated with weak adhesion 
(Liwosz et al., 2006). On the other hand, hypo-glycosylated E-cadherin forms stable AJs 
(Sengupta et al., 2010) 
 
DPAGT1 expression has been shown to modulate the N-glycosylation status of E-
cadherin by impacting AJ organization in MDCK cells (Sengupta, et al, 2010) (Figure 3). 
Several OSCC cell lines exhibit hyper-activation of DPAGT1, which aligns with the 
modification of E-cadherin with complex N-glycans leading to a decreased interaction of 
AJs with stabilizing proteins γ-catenin, α-catenin, and vinculin and their reduced stability 
(Nita-Lazar et al., 2009).  
 
In contrast, downregulation of DPAGT1 expression with siRNA results in reduced 
modification of E-cadherin with complex N-glycans which then drives increased 
recruitment of γ-/α-catenins and vinculin to AJs and re-establishment of their stability. 
Such formation of mature AJs then promotes the assembly of tight junctions (Sengupta, et 
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al., 2010).  The goal of this study was to characterize DPAGT1 expression in CAL27 and 
HSC-3 and gain insights into the role of N-glycosylation in OSCC biology. 
 
	  
Figure 3. Schematic of DPAGT1/Wnt/E-cadherin network. Schematic illustrating the 
positive and negative feedback loops among E-cadherin, canonical Wnt signaling and 
DPAGT1/N-glycosylation. Canonical Wnt signaling activates DPAGT1 transcription, and 
DPAGT1 promotes N-glycosylation of Wnt components to further enhance Wnt signaling. 
High DPAGT1 expression causes extensive N-glycosylation of E-cadherin, which, in turn, 
inhibits E-cadherin adhesion. Under conditions of diminished canonical Wnt signaling, 
DPAGT1 expression is reduced, leading to hypoglycosylation of E-cadherin. 
Hypoglycosylated E-cadherin inhibits canonical Wnt signaling by depleting β- and γ-
catenins from promoters of target genes, including the DPAGT1 promoter, thus 
maintaining low canonical Wnt activity, DPAGT1 expression and the hypoglycosylated 
status of E-cadherin in mature AJs. 
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MATERIALS AND METHODS  
 
CELL CULTURE AND PREPARATION OF CELL LYSATES 
 
CAL27 and HSC-3 cells were maintained in DMEM (Invitrogen) and supplemented 
with 10% fetal bovine serum, penicillin and streptomycin. After 48h, the media were 
changed and cells were divided into several plates and further expanded. Media were 
changed every 2–3 days. After 2 weeks, cells were processed for preparation of total cell 
lysates. For total cell lysates, CAL 27 and HSC-3 cells were  extracted with 600 µl of ice-
cold Triton X-100/β-octylglucosidase buffer (10 mM imidazole, 100 mM NaCl, 1 mM 
MgCl2, 5 mM Na2EDTA, 1% Triton X-100, 0.87 mg/ml β-octylglucosidase) containing 50 
µg/ml aprotinin, 25 µg/ml soybean trypsin inhibitor, 100 µM benzamidine, 5 µg/ml 
leupeptin and 0.5 µM PMSF. Protein concentrations were determined using BCA protein 
assay (Pierce). 
 
REAGENTS  
 
Monoclonal antibodies to E-cadherin, β-catenin, γ-catenin, α-catenin, CD44 and 
IgG isotype controls were obtained from BD Transduction Laboratories. Polyclonal 
antibodies. Monoclonal antibodies to Myc tag, GSK-3β and polyclonal antibody to pGSK-
3β were from Cell Signaling Technology. Monoclonal antibody ABC were from  Millipore, 
respectively. Monoclonal antibody to pan-actin Ab-5 was from NeoMarkers while 
polyclonal antibody to GAPDH was from Sigma. Rabbit polyclonal antibody to hamster 
GPT was prepared commercially (Covance Research Products, Inc.). 
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IMMUNOBLOTS 
 
Cell and tissue lysates were fractionated on 7.5 or 10% SDS-polyacrylamide gel, 
transferred onto polyvinylidene difluoride membranes, blocked with 10% nonfat dry milk, 
and incubated with primary antibodies to selected proteins and processed as described 
(Nita-Lazar et al., 2010) 
 
IMMUNOPRECIPITATION AND FLAG  
 
Equal amounts of TCL (200 µg) were precleared with IgG isotype control 
antibodies and 30 µl of protein G-coupled Sepharose beads (GE Healthcare) or protein A-
coupled Agarose beads, incubated for 2 h at 4°C with 2.5 µg of antibodies against for E-
cadherin or Myc, FLAG, followed by incubation with protein G or A beads. To assure 
specificity, all immunoprecipitation studies routinely included IgG controls. The beads 
were washed three times with lysis buffer (10 mM Tris–HCl, pH 7.5, 1 mM EDTA, 1 mM 
EGTA and 0.5% Triton X-100), samples were resuspended in 100 µl of 2×SDS sample 
buffer, boiled for 5 min at 95°C and analyzed by immunoblot. TCLs from CAL 27 and 
HSC-3 cells with either E-cad- or V13-FLAG- tagged constructs were prepared in RIPA 
buffer. Exogenous E-cadherins were pulled down by treating TCLs (300 µg) with FLAG-
M2 agarose (Sigma) at 4°C for 2 h. Proteins were eluted using 2×SDS sample buffer and 
analyzed by immunoblot.  
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TISSUE SPECIMEN 
 
All studies with surgical OSCC specimens were approved by the Institutional 
Review Board at the Boston University Medical Campus. Fresh tissues were obtained from 
patients with moderately differentiated to poorly differentiated OSCC of the tongue, 
maxillary gingiva, and floor of mouth. Regions of OSCC and adjacent epithelia (AE), 
defined by an on-site pathology analysis, were snap-frozen at −80°C. Tissues were divided 
for H&E analyses, biochemistry, and immunofluorescence staining. OCT-embedded fresh 
tumor tissues were used for the preparation of frozen sections (5 µm). One frozen section 
was set aside for H&E staining, whereas the remaining sections were processed for 
immunofluorescence analyses as described below. For biochemical analyses, total tissue 
lysates (TTLs) from AE and OSCC were prepared by extraction with Triton X-100/β-octyl-
glucoside buffer as described previously. Protein concentrations were determined using the 
BCA assay (Pierce). 
 
IMMUNOFLUORESCENCE  
 
For immunofluorescence analyses, cells were plated in chamber slides at a density 
of 5–6 × 103/cm2. For indirect immunofluorescence analyses of human AE and OSCC 
specimens, tissue sections were blocked with 10% goat serum and incubated with 
antibodies against selected proteins, followed by secondary antibodies conjugated with 
FITC. Negative controls lacked primary antibodies. The slides were mounted in 
VECTASHIELD, and optical sections were analyzed with either a Nikon Eclipse TE300 
microscope or a Zeiss LSM 510 META confocal microscope. 
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FLOW CYTOMETRY 
 
CAL27 and HSC-3 cells were trypsinized from monolayer and collected by 
centrifugation. After surface labeling with lectins PHA-L and ConA, the cells were 
resuspended in 1 ml of PBS at RT, transferred to 4 ml of absolute ethanol and placed at –
20°C for 5-15 min after which they were resuspended in 5 ml of PBS for 15 min. Next, the 
cells were treated with ribonuclease (1 mg/ml) for 5 min at RT and resuspended in 200 µl 
of 3 µM PI solution. After sorting cells according to PHA-L and ConA lectins’ binding 
base on N-glycan expression, analyses were performed with FACScan (Becton Dickinson) 
and CellQuest Pro software. 
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RESULTS 
 
DPAGT1 expression is associated with metastatic characteristics of OSCC HSC-3 cells. 
 
Immunofluorescence analyses of DPAGT1 expression showed that it was 
prominently expressed in CAL27 and HSC-3 cells, with increased fraction of GPT in HSC-
3 cells (Figure 4).  Previous studies revealed a crosstalk between E-cadherin/DPAGT1/Wnt 
signaling with DPAGT1 being a downstream target of the Wnt/β-catenin pathway (Nita-
Lazar et al., 2009, Sengupta et al. 2010). 
 
 Since a common feature of OSCC in human specimens is the aberrant expression of 
DPAGT1 and Wnt signaling leading to an increased modification of E-cadherin with 
complex N-glycans and eventually lost of intercellular adhesion, the high N-glycosylation 
activity in OSCC cells may drive the loss of AJs (Sengupta et al., 2013; Jamal et al., 2009; 
Nita-Lazar, 2009). Indeed, previous studies have shown that high level of N-glycosylation 
compromised the ability of E-cadherin to inhibit canonical Wnt signaling and DPAGT1 
expression.  
 
Further, transfection of hypo-glycosylated E-cadherin into CAL27 and A253 cells 
(A253, human salivary epidermoid carcinoma cell line) inhibited DPAGT1 expression and 
canonical Wnt signaling via depletion of β- and γ-catenins from the DPAGT1 promoter and 
promoters of Wnt target genes (Jamal et al., 2009). Thus, higher level of GPT in HSC-3 
cells is associated with increased nuclear β-catenin. Since upregulation of DPAGT1 plays a 
pivotal role in driving canonical Wnt signaling and repressing E-cadherin adhesion, these 
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results suggest that DPAGT1 and b-catenin function together to promote aggressive 
features in OSCC cells.  .   
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Figure 4.  Immunofluorescence localization of GPT and β-catenin.  
Shown are 0.74 µm thick confocal. Images represent one of two independent experiments.   
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EXPRESSION OF COMPLEX N-GLYCANS OF PHA AND ConA in CAL27AND HSC-
3 CELLS 
	  
 
To determine if higher levels of GPT found in HSC-3 cells were associated with 
increased cell surface presentation of complex N-glycans, we examined the binding of 
HSC-3 and CAL27 cells to lectins specific for either complex N-glycans, PHA-L or high 
mannose/hybrid N-glycans (Con-A) by flow cytometry.  
 
As shown in Figure 5, HSC-3 cells exhibited robust surface expression of complex 
N-glycans based on PHA-L and ConA lectin binding. This correlated with high expression 
of DPAGT1/GPT in HSC-3 cells. In contrast, CAL27 cells showed increased binding to the 
ConA lectin indicating their preferential modification with high mannose/hybrid N-glycans.  
 
In an orthotropic mouse model of tongue cancer, CAL27 cells form tumors that do 
not metastasize. In contrast, HSC-3 cells generate tongue tumors that spread to the lungs, 
liver and bone, resembling sites of metastasis in humans. The results demonstrating the 
high abundance of complex N-glycans on the surface of HSC-3 cells suggest that N-
glycans may serve as biomarkers of OSCC invasive features (Figure 5). 
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Figure 5. Immunofluorescence localization of PHA and ConA lectins.  
Shown are 0.74 µm thick confocal sections. Data were obtained using duplicate samples 
from different experiments. 
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GSK3-β  ACTIVITY in CAL27 and HSC3 CELLS 
 
To determine the underlying cause for the increased levels of nuclear β-catenin in 
metastatic HSC-3 cells compared to non-metastatic CAL27 cells, we assessed the activity 
of glycogen synthase kinase 3 (GSK3β), a serine/threonine protein kinase that mediates the 
addition of phosphate molecules onto serine and threonine amino acid residues, in total cell 
lysates by Western blot analysis. GSK3β functions as a kinase for over forty different 
proteins in a variety of different pathways, most prominent of which include cellular 
proliferation, migration, glucose regulation, and apoptosis (Adnan et al., 2001; Tejeda-
Muñoz, N. and Robles-Flores, M, 2015).  
 
In particular, GSK3β phosphorylates N-terminal residues of β-catenin within a short 
linear motif responsible for binding TrCP1 (also known as β-TrCP) E3 ubiquitin ligase 
when phosphorylated and subsequent degradation via the proteosome pathway. However, 
phosphorylation of GSK3β at serine 9 by the PI3Kinase pathway leads to its inactivation, 
thus allowing cytoplasmic accumulation of β-catenin and its translocation to the nucleus 
where it functions as a co-transcriptional activator of multiple pro-tumorigenic genes. 
 
Western blot analyses of total cell lysates showed that in HSC-3 cells, levels of p-
GSK3β were increased compared to CAL27 cells (Figure 6). This result was consistent 
with increased nuclear β-catenin and GPT levels in HSC-3 cells (Figure 4). Further, since 
β-catenin activates DPAGT1 expression and induces the N-glycosylation pathway, 
inactivation of GSK3β is the likely factor driving modification of E-cadherin and other key 
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glycoproteins with complex N-glycans (Figure 5). In addition, since phosphorylation of  
GSK3β at serine 9 occurs through inappropriate activation of the PI3K/Akt pathway, the 
latter is likely to be responsible for the aggressive phenotype of HSC3 cells.  
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Figure 6. CAL 27 & HSC-3 cells quantitations of GSK3-β  & inactive GSK3-β . 
(A) TCLs from CAL27 and HSC-3 cells were examined for GSK3-β and inactive p-GSK3-β 
in comparison to GAPDH by WB using data from three independent experiments. (B & C)  
Fold changes of GSK3-β (B) and inactive p-GSK3-β (C) protein from CAL 27 cells was 
determined in comparison to HSC-3 cells after normalization to GAPDH using data from 
three independent experiments (*P<0.05). 
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CHARACTERIZATION of AJs in CAL27 and HSC-3 CELLS. 
	  
	  
Previous studies have shown that increased DPAGT1 expression is associated with 
extensive N-glycosylation of E-cadherin with complex oligosaccharide structures, which 
precludes its interaction with the stabilizing proteins γ-catenin and α-catenin and with the 
actin cytoskeleton, leading to destabilization of AJs (Nita-Lazar et al., 2009; Nita-Lazar et 
al., 2010). Since HSC-3 cells display an invasive phenotype while CAL27 cells do not, we 
predicted that HSC-3 would also have compromised E-cadherin junctions.   
 
Therefore, we determined the extent of association of β-catenin, γ-catenin and α-
catenin with E-cadherin protein complexes in HSC3 and CAL27 cells by co-
immunoprecipitation of E-cadherin and associated catenins from total cell lysates.  As 
shown in Figure 7, HSC-3 cells had lower abundance of E-cadherin compared to CAL27 
cells. Normalization of catenins’ levels in association with E-cadherin in the 
immunoprecipitates revealed reduced interaction of E-cadherin with β-catenin and γ-
catenin in HSC-3 cells compared to CAL27 cells.  
 
Further, while levels of α-catenin were low in CAL27 cells, they were barely 
detectable in HSC-3 cells, suggesting that OSCC cells were characterized by an overall low 
association of E-cadherin junctions with the actin cytoskeleton.  Thus, the diminished 
stability of AJs in HSC-3 cells was consistent with these cells’ more invasive and 
malignant phenotype.  
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In addition to E-cadherin, β-catenin plays a central role in Wnt signaling providing a 
direct link between cellular adhesion and proliferation. Here, the finding that β-catenin is 
less associated with AJs in HSC-3 cells	  is consistent with increased nuclear β-catenin and 
cellular GPT levels in HSC-3 cells and provides an explanation for these cells’ more 
invasive phenotype.   
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Figure 7. Characterization of E-cadherin junctions in CAL27 and HSC-3 cells.  
(A) E-cadherins were immunoprecipitated from total cell lysates and analyzed for 
association with β-catenin, γ-catenin and α-catenin by WB using antibodies specific to E-
cadherin, β-catenin, γ-catenin and α-catenin. (B) Fold changes in protein levels associated 
with E-cadherin complexes from CAL 27 cells were determined after normalization to E-
cadherin abundance with data from three independent experiments (*P<0.05). (C) Fold 
changes in protein levels associated with E-cadherin complexes from HSC-3 cells were 
determined after normalization to E-cadherin abundance with data from three independent 
experiments (*P<0.05). (D) Controls for immunoprecipitation experiments. 
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OVEREXPRESSION OF DPAGT1 MARKS SUBPOPULATIONS OF LESS 
DIFFERENTIATED CELLS IN MILD DYSPLASIA.   
 
OSCC is known to progress through a multistep process from normal histologic 
features to hyperplasia, mild dysplasia, moderate dysplasia, severe dysplasia, carcinoma in 
situ (CIS), invasive carcinoma and metastasis. To align our in vitro findings with non-
malignant CAL27 and malignant HSC-3 cells with the clinical course of the disease, we 
analyzed E-cadherin and DPAGT1 expression and localization immunofluorescence 
staining coupled with high-resolution confocal imaging in human oral tissues presenting as 
mild dysplasia.  
 
In the majority of cells in these tissue specimens, E-cadherin was well focused at the 
cell membranes indicating the presence of mature AJs. In these cells, expression of the 
DPAGT1 protein, GPT, was typically low. In contrast, in the basal cell layer, E-cadherin 
was more diffuse, and GPT expression was increased, as expected for proliferating cells. 
Nonetheless, there were some cells within the differentiating suprabasal and spinous cell 
layers where E-cadherin was found to be more diffuse suggesting diminished mature 
junctions and a likely loss of cell architecture. This coincided with a more prominent 
expression of GPT in these cells.  Collectively, these results showed that mild dysplasia 
was associated with regions of increased DPAGT1 expression and reduced junctional 
association of E-cadherin.   
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Figure 8. Immunofluorescence localization of E-cadherin and GPT in tissues from 
patients exhibiting mild dysplasia.  
DAPI was used to stain nuclei. A zoomed in image from each sample is shown in panels, 
highlighting (arrow) the GPT localization and E-cadherin changes observed in the basal 
layer of the epithelium and diffused E-cad in cells within the suprabasal layers. Scale bars 
represent 20µm. 
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OVEREXPRESSION OF DPAGT1 MARKS IMMATURE CELLS IN MODERATE 
DYSPLASIA.   
 
Moderate dysplasia specimens usually appear to have a proliferation of atypical 
cells extending into the middle one-third of the epithelium. The cytological changes are 
more severe than in mild dysplasia and changes such as hyperchromatism, and prominent 
cell and nuclear pleomorphism may be seen. Increased and abnormal mitoses may be 
present, but these are usually located in the basal layers. Micro-architectural changes may 
be observed in the lower half of the epithelium where there may be loss of basal polarity 
and hyperplasia leading to bulbous rete pegs.  However, stratification and maturation are 
relatively normal, often with hyperkeratosis. 
 
Examination of E-cadherin and DPAGT1 expression revealed increased GPT levels 
beyond the basal layer extending into the differentiating epithelium. This demonstrated that 
changes in the cellular architecture were associated with upregulated GPT and loss of 
epithelial morphology.   
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Figure 9. Immunofluorescence localization of E-cadherin and GPT in tissues from 
patients exhibiting moderate dysplasia.  
DAPI was used to stain nuclei. A zoomed in image from each sample is shown in panels, 
highlighting (arrow) the GPT localization and E-cadherin changes observed in the basal 
layer of the epithelium and diffused E-cad in cells within the suprabasal layers. Scale bars 
represent 20µm. 
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OVEREXPRESSION OF DPAGT1 MARKS DISCOHESIVE AND IMMATURE 
CELLS IN CARCINOMA IN SITU. 
 
CIS is the most severe form of epithelial dysplasia and is characterized by full 
thickness cytological and architectural changes. The epithelium is almost completely 
disrupted with atypical and hyperchromatic nuclei are seen among the superficial cells; 
however, there is still some evidence of maturation. Typically, in the connective tissue 
stroma, there was accumulation of chronic inflammatory cells. 
 
Analyses of human CIS specimens showed prominently but diffuse E-cadherin 
expression throughout the diseased epithelium that coincided robust expression of GPT. 
This suggested that cells in the differentiating layers of oral epithelia did not maintain 
junctional E-cadherin and lost their mature architecture. Such loss of E-cadherin junctions 
has been shown to preclude its function as a tumor suppressor leading to unwarranted 
activation of canonical Wnt signaling and DPAGT1 expression that, in turn, allows 
unwarranted cell proliferation (Sengupta et al., 2013; Jamal, et al., 2009).  Collectively, 
these results confirmed our findings with CAL27 and HSC-3 cells lines showing that loss 
of E-cadherin adhesion and activation of the Wnt/β-catenin/DPAGT1 axis are features of 
invasive OSCC cells that are maintained during the clinical course of this disease.   
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Figure 10. Immunofluorescence localization of E-cadherin and GPT in tissues from 
patients exhibiting carcinoma in situ. 
 DAPI was used to stain nuclei. A zoomed in image from each sample is shown in panels, 
highlighting (arrow) the GPT localization and E-cadherin changes observed in the basal 
layer of the epithelium. Scale bars represent 20µm. 
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DISCUSSION 
 
Our studies show that upregulated N-glycosylation in OSCC occurs as a result of 
increased levels of DPAGT1, the gene that encodes GPT, the rate-limiting enzyme in the 
N-glycosylation pathway. Increased GPT/N-glycosylation promotes the activity of the co-
transcriptional regulator, β-catenin, one of the key effectors of canonical Wnt signaling. In 
human OSCC tissues, DPAGT1/GPT and canonical Wnt signaling function in a positive 
feedback loop, which leads to inappropriate upregulation of a secreted N-glycoprotein 
which drives migratory and invasive properties in OSSC cells in vitro (Kukuruzinska, 
2014).  
 
To date, numerous OSCC cell lines have been established. However, since the 
growth patterns and invasive characteristics of these cell lines differ from each other, not all 
are suitable for modeling OSCC biology in vitro and in vivo. The CAL27 cell line was 
established by Gioanni in 1982. When tested for tumorigenicity in athymic nude mice 6 
weeks after subcutaneous injection of 2 x 106 CAL 27 cells in both flanks of 10 mice, solid 
tumors developed in 8 of the 20 injection sites. The growth of CAL27-derived tumor 
xenografts was rapid, about 3-5 mm per week (Gioanni et al., 1988). In contrast, the HSC-3 
cell line-derived tumors in mice grow slowly but they have the ability to metastasize even 
from small size tumors. This cell line was derived from a moderately differentiated primary 
tumor located in the tongue with metastatic properties (Erdem et al, 2007).  
 
Protein N-glycosylation has emerged as a central regulator of tissue homeostasis 
and its dysregulation has been associated with OSCC initiation and progression to 
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aggressive disease (Jamal et al, 2009; Nita-Lazar et al, 2009; Liu et al., 2013). The results 
presented here show that aberrant upregulation of a key N-glycosylation-regulating gene, 
DPAGT1, is associated with increased nuclear β-catenin levels and with the increased  
presentation of complex N-glycans on the cell surface. Thus, N-glycans may serve as novel 
biomarkers of metastatic properties of OSCC.  
 
E-cadherin junctions comprise different proteins whose dynamic interactions 
regulate AJs stability, although the molecular details of these relationships are not well 
understood. This study provides evidence that N-glycosylation and nuclear β-catenin are 
coordinately dysregulated in OSCC cells, with increased GPT expression and nuclear β-
catenin localization being associated with aggressive properties.  While the etiology of 
OSCC remains poorly understood, the upstream signals driving dysregulation of the 
DPAGT1/β-catenin feedback loop may include mutations in these pathways as well as 
overproduction/availability of UDP-GlcNAc from the hexosamine pathway. Further studies 
are needed to determine the cues that promote deregulation of the GPT/β-catenin feedback 
loop.  
 
Interestingly, the DPAGT1/canonical Wnt signaling axis contributes to epithelial-to-
mesenchymal transition (EMT) explaining in part the metastatic properties of HSC-3. EMT 
underlies aggressive cancer features and is associated with the development of stem-like 
properties of head and neck cancer cells (Mani et al, 2008). Both N-glycosylation and Wnt 
signaling have been shown to be associated with the stem-like phenotype, with Wnt 
signaling being required for the maintenance of stem cell niches (Schwitalla et al,) and with 
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induced canonical Wnt being a feature of cancer initiating cells in human salivary glands 
and head and neck cancer (Went et al, 2013). On the other hand, N-glycosylation has been 
shown to be required for the presentation of stem cell surface markers and their function 
(Cummings et al., 2009). 
 
OSCC is known to progress through a multistep process from normal histologic 
features to hyperplasia, mild dysplasia, moderate dysplasia, severe dysplasia, carcinoma in 
situ (CIS), invasive carcinoma and metastasis. The diagnosis and grading of oral epithelial 
dysplasia is based on a combination of architectural and cytological changes (Silverman et 
al, 1084). As seen in human tissues samples, this multistep process may be explained, in 
part, by molecular changes in the DPAGT1/Wnt signaling axis, though the etiology and 
origin of this imbalance in the majority of different cancer types have not yet been 
determined. We have observed that similar changes in N-glycan presentation on OSCC 
tumor cell surfaces are aligned with the OSCC multistep process by mechanisms that 
promote tumor initiation (neoplasm), progression and metastasis accompanied by complex 
pathologic characteristics (Hanahan et al., 2011). Our results show that the increase in the 
severity of oral dysplasia and progression to OSCC is associated with a gradual increase in 
GPT expression and less junctional E-cadherin. 
 
The present study provides new insights into how N-glycosylation may promote the 
aggressive behavior of OSCC cells. Given the importance of cell line selection for cancer 
studies, characterization of factors affecting cell growth in vitro and in vivo is of 
importance. This study identifies DPAGT1/GPT as one of the OSCC aggressive features 
and suggests that N-glycans may be powerful biomarkers of this disease.  
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